Organization
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
3 clinical trials
Clinical trial
Implementation of Out-of-HOspital Administration of the Long-Acting Combination Cabotegravir+Rilpivirine as an Optional Therapy in HIV-Infected Patients From Spain: Acceptability, Appropriateness, Feasibility and Satisfaction: The HOLA StudyStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Repurposing Clinically Approved Drugs for Yaws With an Insight Into the Cutaneous Ulcer Disease Syndrome (Trep-AByaws)Status: Active (not recruiting), Estimated PCD: 2024-06-20
Clinical trial
Break-through Infection Following Mpox vaccinatIon: Target Trial EmulationStatus: Completed, Estimated PCD: 2024-03-30